Yorktown Management & Research Company’s Medpace MEDP Stock Holding History

Yorktown Management & Research Company’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$953K	Hold	1,800	–	–	0.58%	43
2026 Q1	$864K	Hold	1,800	–	–	0.72%	33
2025 Q4	$1.01M	Hold	1,800	–	–	0.81%	20
2025 Q3	$925K	Hold	1,800	–	–	0.74%	27
2025 Q2	$565K	Hold	1,800	–	–	0.54%	55
2025 Q1	$548K	Hold	1,800	–	–	0.6%	49
2024 Q4	$598K	Hold	1,800	–	–	0.57%	50
2024 Q3	$601K	Hold	1,800	–	–	0.62%	52
2024 Q2	$741K	Hold	1,800	–	–	0.8%	26
2024 Q1	$727K	Hold	1,800	–	–	0.69%	29
2023 Q4	$552K	Hold	1,800	–	–	0.58%	50
2023 Q3	$436K	Hold	1,800	–	–	0.49%	68
2023 Q2	$432K	Hold	1,800	–	–	0.46%	88
2023 Q1	$338K	Hold	1,800	–	–	0.37%	115
2022 Q4	$382K	Hold	1,800	–	–	0.47%	91
2022 Q3	$283K	Buy	+1,800	New	+$287K	0.37%	112

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Yorktown Management & Research Company's MEDP Position: Q2 2026 in Review

Yorktown Management & Research Company held its Medpace (MEDP) position steady in Q2 2026 at 1,800 shares worth $953K. The position accounts for 0.58% of the portfolio, ranked #43.

Yorktown Management & Research Company first reported a position in MEDP in Q3 2022 and has held it in 16 quarters since. The position peaked at $1.01M in Q4 2025. 699 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

Yorktown Management & Research Company held 1,800 shares of Medpace worth $953K as of Q2 2026.
Yorktown Management & Research Company left its Medpace share count unchanged in Q2 2026.
Medpace made up 0.58% of Yorktown Management & Research Company's portfolio in Q2 2026, its #43 holding.
Yorktown Management & Research Company first reported a position in Medpace in Q3 2022 and has held it in 16 quarters since.
Yorktown Management & Research Company's Medpace position peaked at $1.01M in Q4 2025.
699 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Yorktown Management & Research Company's 13F filing for Q2 2026, filed 23 Jul 2026.